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Objective: Due to the high risk of life-threatening side effects, nonsteroidal anti-inflammatory 
drugs (NSAIDs) are not favored for treating persistent nonmalignant pain in the elderly. We 
report national prescription trends with determinants of NSAIDs prescription for persistent 
nonmalignant pain among older patients (age 65 and over) in the US outpatient setting.
Methods: A cross-sectional analysis was performed using National Ambulatory Medical Care 
Survey data. Prescriptions for NSAIDs, opioids, and adjuvant agents were identified using 
five-digit National Ambulatory Medical Care Survey drug codes.
Results: About 89% of the 206,879,848 weighted visits in the US from 2000 to 2007 recorded 
NSAIDs prescriptions in patients (mean age =75.4 years). Most NSAIDs users had Medicare 
(75%), and about 25% were prescribed with adjuvant medications considered inappropriate for 
their age. Compared to men, women were 1.79 times more likely to be prescribed NSAIDs.
Conclusion: The high percentage of NSAIDs prescription in older patients is alarming. We 
recommend investigating the appropriateness of the high prevalence of NSAIDs use among 
older patients reported in our study.
Keywords: pain management, NSAIDs, inappropriate adjuvant, AGS guideline, NAMCS
Introduction
Persistent or chronic pain associated with nonmalignant medical conditions is a com-
mon chronic health problem in older adults.1 Besides incurring the high health care cost 
of about $635 billion in medical care and lost productivity in the US, persistent pain 
is also highly salient for functional impairment, sleep disturbance, decreased appetite 
with weight loss, and depression, ultimately leading to decreased quality of life and 
even failure to thrive.2–4 Medication is the most common intervention in managing 
persistent pain, and older patients are at greater risk of adverse drug reactions (ADRs) 
due to age-related physiological changes, multiple comorbidities, and polypharmacy.4–7 
The American Geriatrics Society (AGS) guidelines for persistent nonmalignant pain 
management in older adults recommend acetaminophen as a first-line agent for mild 
to moderate pain.4–7 In inflammatory pain conditions, nonsteroidal anti-inflammatory 
drugs (NSAIDs) are known to provide superior short-term relief compared to acet-
aminophen.8,9 However, NSAIDs possess a higher potential for life-threatening side 
effects in older adults, such as gastrointestinal bleeding, renal toxicity, and cardiovascu-
lar events,10 making NSAIDs a medication to use with caution in the vulnerable elderly 
population. Guidelines provided by the AGS emphasize pain control with NSAIDs 
among patients in whom other therapies have failed and goals to control persistent 
pain were not achieved. However, AGS guidelines recommend doing so with great 





caution, and only after appropriate assessment by clinicians.4 
The prevalence of NSAIDs use for persistent pain among the 
general US adult population has been estimated to be 95%.11 
However, studies addressing NSAIDs use for persistent pain 
in the geriatric population worldwide have been sporadic and 
yield conflicting results regarding the prevalence of NSAIDs 
use for nonmalignant pain management.
One analysis of a national database from the 1980s and 
the 1990s on prescription analgesic use in older Americans 
reported that the prevalence of prescription NSAIDs use in 
the preceding month was between 8% and 13%, with greater 
usage rates in females (12%–13%) compared to males 
(8%–9%).12 Similarly, in a cohort of over 2,000 Finnish older 
adults, approximately 8% used NSAIDs to relieve chronic 
joint or back pain.13 Alternatively, in a Spanish study of over 
17,000 osteoarthritis patients, nearly 80% used NSAIDs for 
chronic pain relief.14 While these studies provide some esti-
mates of the prevalence of NSAIDs use among older adults, 
most US studies are limited to descriptions of prevalence by 
sex and cost related to NSAIDs prescriptions filled by older 
patients,15–20 and lack information on determining factors 
associated with NSAIDs use in the elderly. Information on 
factors influencing NSAIDs prescriptions among the general 
community-dwelling elderly population is essential for iden-
tifying risk factors and appropriateness of prescribing, and 
may educate clinicians on AGS guidelines to help improve 
health quality while adequately managing persistent pain. 
We describe national prescription trends with determinants 
of NSAIDs prescription for nonmalignant pain management 
among older patients (aged 65 years and over) in the US 
outpatient settings using the National Ambulatory Medical 
Care Survey (NAMCS) data from 2000 to 2007.
Methods
This cross-sectional analysis utilized data from NAMCS 
provided by the Centers for Disease Control and Prevention 
(CDC) and the National Center for Health Statistics from 
2000 to 2007. The NAMCS employed a multistage probabil-
ity design; more information about the NAMCS sampling and 
weighting methods can be found on the NAMCS webpage 
(http://www.cdc.gov/nchs/ahcd.htm).21,22
Physician–patient office visits were used as the primary 
sampling unit. We followed AGS guidelines to identify appro-
priate patients aged 65 years or older who visited outpatient 
clinics for nonmalignant pain management;4 these were: 
1) documented by patients’ self-reported reason for visit; 
2) International Classification of Diseases, Ninth Revision 
code for assessment of persistent nonmalignant pain recorded 
by physician for that visit; or 3) prescription received for pain 
management during that visit. Reports of chronic pain were 
further categorized into the four classifications of chronic 
pain: neuropathic, muscle, inflammatory, and mechanical/
compressive, as determined by the Institute for Clinical 
Systems Improvement guidelines.15,16 Additionally, reports 
of two or more types of chronic pain by a single patient were 
categorized separately. The NAMCS survey used office visit 
forms in order to extract information regarding patients’ demo-
graphics, insurance status, reason for visit, known diagnoses, 
current and prescribed medication(s), and recommended 
services. Identification of prescriptions for NSAIDs, opioids, 
and adjuvant agents were identified by using the unique five-
digit NAMCS drug codes. Each variable in the study was 
coded before beginning the statistical analysis. Because this 
investigation used de-identified data available through the 
CDC, the study was exempt from IRB review.
Bar graphs describe the trend of NSAIDs prescription 
in the study population over 8 years (from 2000 to 2007) 
with a graphic representation. Descriptive statistics report 
patient and physician characteristics, regional distributions, 
types of medication, and insurance for all patients as well as 
those who received NSAIDs prescriptions only for persistent 
nonmalignant pain. A multivariate logistic regression model 
using the variables described above reports the determinants 
of prescribing NSAIDs for persistent nonmalignant pain. 
The multivariate model included all visits reporting pre-
scriptions written for NSAIDs for persistent non malignant 
pain. All analyses were weighted to determine nationally 
representative estimates. The statistical software STATA® 
version 11 was used for all analyses (StataCorp LP, College 
Station, TX, USA). Statistical significance was assessed at 
the P,0.05 level.
Results
We analyzed a total of 206,879,848 weighted (5,968 
unweighted) outpatient visits for patients aged 65 years or 
older with nonmalignant pain from 2000 to 2007. About 89% 
of these visits recorded a clinician prescribing NSAIDs. The 
mean age for NSAIDs prescription recipients was 75.4 years, 
with the majority being women (68%) and non-Hispanic 
white (87.6%) (Table 1). A large percentage of the NSAIDs 
users had Medicare (75%), while 15% had private insurance. 
Most patients with NSAIDs (68.8%) received a total of four 
or fewer prescriptions during the outpatient visit (Table 1). 
About a quarter of the NSAIDs users were also prescribed 
adjuvant agents that are considered inappropriate for the 
geriatric population (Table 1).
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Figure 1 Patients (aged $65 years) nSaiDs usage 2000–2007.
Abbreviations: NSAIDs, nonsteroidal anti-inflammatory drugs; P N MP, persistent 
non-malignant pain.
Table 1 Description of patient, physician, regional, and insurance 
characteristics for all patients versus those who received 
nSaiDs prescriptions (206 million weighted cross-sectional 
patients $65 years using naMcS data from 2000 to 2007)








age (years)   
 Mean 75.5 75.4
 SD (±) 11.6 11.7
gender (%)  
 Male 33.00% 32.00%
 Female 67.00% 68.00%
region (%)   
 northeast 21.00% 21.90%
 Midwest 22.00% 21.40%
 South 36.00% 35.90%
 West 21.00% 20.80%
race/ethnicity (%)   
 Hispanic 7.10% 7.10%
 non-Hispanic 92.90% 92.90%
 White 87.60% 87.60%
 Minority 8.60% 8.80%
 Other‡ 3.80% 3.70%
Payment source (%)   
 Medicare 75.60% 74.70%
 Medicaid 4.90% 4.90%
 Private insurance 14.00% 14.70%
 Other insurance 5.50% 5.70%
number of medications   
 Patients on #4 medications 63.00% 68.80%
 Patients on $5 medications 36.80% 31.20%
Type of medications (%)   
 nSaiDs 89.60% 100.00%
 Opioids 10.80% 10.40%
adjuvant agent* 27.01% 26.18%
 Tricyclics 1.30% 1.28%
  Other antidepressants/ 
anticonvulsants
12.70% 11.90%
 antirheumatics 1.30% 1.30%
 Muscle relaxant 2.10% 2.00%
 corticosteriods 9.60% 9.60%
 Topical agents (capsaicin) 0.04% 0.04%
Type of pain reported (%)   
 neuropathic pain 3.75% 3.37%
 Muscle pain 3.88% 3.93%
 Inflammatory pain 27.80% 27.95%
 Mechanical pain 13.61% 13.73%




Physician specialty (%)   
 Family practice 21.40% 20.90%
 internal medicine 28.30% 26.80%
 Orthopedic surgery 15.10% 16.50%
 Pain medicine 0.10% 0.10%
(Continued)
Table 1 (Continued)








 Psychiatry 3.90% 4.40%
 rheumatology 6.00% 6.40%
 geriatric medicine 0.90% 0.90%
 neurology 1.30% 1.30%
 general practice 2.40% 2.50%
 Other specialties 20.70% 20.20%
established patient 93.74% 93.50%
Notes: Physican specialty reports the distribution of visits to different specialties 
among those who received nSaiDs prescriptions. *adjuvant agents include: 
tricyclic antidepressants, SSris, anticonvulsants, antirheumatics/immunologics, 
muscle relaxants, topical products (capsaicin), and corticosteroids; ‡other race 
includes African American, Asian/Native Hawaiian/Other Pacific Islander, American 
indian/alaskan native, and cases where more than one race was reported.
Abbreviations: naMcS, national ambulatory Medical care Survey; nSaiDs, 
nonsteroidal anti-inflammatory drugs; PCP, primary care provider; SD, standard 
deviation.
Figure 1 displays the trend of NSAIDs use nationally in 
older adults (aged 65 years and over) from 2000 to 2007. 
Although fluctuations were observed, there was no significant 
increasing or decreasing trend in the prescribing of NSAIDs 
among the geriatric population during the study period.
Table 2 reports determinants of NSAIDs prescribing in 
the geriatric population. Sex, geographical region, number 
of concurrent medications, and provider status significantly 
impacted prescribing patterns (P,0.05). Women were 1.79 
times more likely to be prescribed NSAIDs for persistent non-
malignant pain compared to men. Patients on four or fewer 
medications were 12.4 times more likely to be prescribed 
NSAIDs compared to patients with five or more medica-
tions. Primary care providers (PCPs) were 37% less likely 
to prescribe NSAIDs compared to non-PCPs.





each year.25,26 Despite the presence of specific guidelines 
that caution the use of NSAIDs among older adults due to 
the risk of ADRs and hospitalizations, our report from a 
national database is concerning for the quality of care in 
older patients, specifically women, who are seeking pain 
management for persistent nonmalignant pain.
About 75% of the current study patients receiving 
NSAIDs prescriptions had Medicare insurance. This is con-
sistent with a report that drug mention rates are significantly 
higher for office visits among patients with Medicare as their 
main expected source of payment.24
Our report of women’s increased likelihood to receive 
NSAIDs compared to men, as well as higher percentages 
(68%) of women receiving NSAIDs, is consistent with a 
previous report of the third National Health and Nutrition 
Examination Survey (NHANES III) data from the 1980s 
and 1990s.27,28 Longer life expectancies among women, 
with a greater number of women than men among the geri-
atric patient population in the US,27 may also explain these 
findings. Women are also known to account for a dispro-
portionately larger share of expenditures for NSAIDs, with 
more women (12.2%–13.0%) using NSAIDs prescriptions 
than men (8.1%–9.1%) of similar age ($65 years) in the 
US.12,29 This is similar to a national drugstore chain report 
on prescription dispensing, which documented a higher 
likelihood of dispensing anti-inflammatory drugs for older 
women compared to men (odds ratio =1.70, 95% confidence 
interval: 1.70–1.70).17
We found that PCPs were 37% less likely to prescribe 
NSAIDs compared to non-PCPs in this geriatric population 
(Table 2). Among those patients receiving an NSAIDs pre-
scription, 26.8% saw an internal medicine specialist, while 
20.9% of these visits occurred with a family practitioner 
(Table 1). Conversely, physicians specializing in geriatrics 
and pain medicine prescribed the smallest percentage of 
NSAIDs (Table 1). Results from the NAMCS data from 2003 
to 2004 showed that the annual rate of reported medications 
(ie, prescription and over the counter medications, immuniza-
tions, allergy shots, anesthetics, and dietary supplements that 
were ordered, supplied, administered, or continued during a 
visit) in primary care offices increased significantly between 
1993–1994 and 2003–2004.24 For patients aged 65 years and 
older, the annual rate of reported number of medications 
was highest in primary care office visits compared to all 
other settings.24 It has been previously reported that PCPs 
treat 52% of chronic pain patients.18 We report consistent 
data, such that 52.3% of all geriatric patients with persistent 
nonmalignant pain visited a PCP, and 50.6% of all geriatric 
Table 2 Logistic regression for factors influencing NSAIDs 
prescription in patients aged $65 years for treatment of persistent 
nonmalignant pain
Variables Patients (aged $65 years)
N=5,968
OR 95% CI P-value
gender   
 Female 1.79 1.37–2.33 ,0.0001
region  
 northeast 1 (reference)  
 West 0.94 0.54–1.64 0.83
 Midwest 0.63 0.41–0.97 0.04
 South 0.95 0.61–1.46 0.8
race/ethnicity  
 White 0.72 0.41–1.27 0.26
 Other race‡ 0.45 0.19–1.11 0.08
 african american 1 (reference)   
 Hispanic 0.66 0.40–1.08 0.1
 non-Hispanic 1 (reference)  
Payment source  
 Medicare 0.52 0.25–1.09 0.08
 Medicaid 0.86 0.32–2.32 0.77
 Private insurance 0.71 0.33–1.54 0.39
 Other insurance 1 (reference)  
number of medications  
  Patients on #4 medications 12.4 8.58–17.92 ,0.0001
established patient 1.04 0.56–1.92 0.91
PcP 0.63 0.46–0.88 ,0.05
Notes: ‡Other race includes African American, Asian/Native Hawaiian/Other Pacific 
islander, american indian/alaskan native, and cases where more than one race was 
reported. The adjusted Wald test was used for categorical variables. reference = 
the comparison groups for regional interpretation.
Abbreviations: CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory 
drugs; Or, odds ratio; PcP, primary care provider.
Discussion
In the current study sample, a large percentage (89.6%) of 
older adults were prescribed NSAIDs for treating persistent 
nonmalignant pain in outpatient settings. Compared to men, 
women had a higher likelihood of receiving a prescription 
for NSAIDs. Patients with concomitant use of four or fewer 
prescriptions or visiting a PCP were less likely than patients 
with at least five prescriptions or visiting non-PCPs to 
receive NSAIDs in our study. Our finding of high percent-
ages of NSAIDs prescription use in the study sample is 
alarming for patients who are at risk of ADRs due to their 
age. However, it is consistent with a CDC briefing that 
reported analgesics to be the most common drug category 
mentioned during outpatient physicians’ office visits in 
2007,23 with NSAIDs being the most commonly prescribed 
type of analgesics for adults over age 65.24 Our data reports 
a much higher percentage of NSAIDs prescription compared 
to previous estimates; we report 18%–40% of adults aged 
65 years and older filling at least one NSAIDs prescription 
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patients receiving a prescription for NSAIDs visited a PCP. 
Our study reports lower percentages of NSAIDs prescribed 
by PCPs compared to non-PCPs. Continuation of care with 
appropriate medication reconciliation by PCPs may be a 
protective factor for preventing ADRs due to NSAIDs use 
in patients treated by PCPs. Special training in geriatrics and 
pain management may have led to the reduced percentage 
of prescriptions written by physicians from these special-
ties. However, a low number of specialty physicians in these 
categories, as well as PCPs with advanced training categoriz-
ing themselves as PCPs (as opposed to geriatricians or pain 
specialists who are treating persistent pain) may have biased 
the outcome by misreporting the specialty type as PCPs. That 
said, it is beyond our scope of investigation to tease out such 
a discrepancy from the current data analysis. We recommend 
future studies targeting geriatricians and pain management 
specialties to more precisely assess the appropriate adherence 
to AGS guidelines for managing persistent nonmalignant pain 
among elderly patients.
The use of NSAIDs for persistent pain among the general 
adult population in the US from 2000 to 2007 was approxi-
mately 95%.11 In comparison, 89.6% of the geriatric popula-
tion in the current study had a prescription for NSAIDs use. 
Continuity of care by PCPs is important in improving quality 
of care. Judicious prescribing of appropriate medications to 
improve persistent pain management and avoid ADRs are 
among the primary goals of the current AGS guidelines. As 
a chronic health problem, PCPs from family medicine and 
internal medicine with or without advanced training in either 
geriatrics and/or pain management may play an important 
role in treating persistent nonmalignant pain among older 
patients. Our report of reduced likelihood of NSAIDs pre-
scriptions by PCPs indicate a positive step toward persistent 
pain management when patients are treated by PCPs. It is 
common for older adults to use multiple medications to treat 
multiple concurrent health conditions, such as hypertension, 
diabetes, high cholesterol, depression, arthritis, and mus-
culoskeletal and chronic pain.19,20 The government agency 
Administration on Aging reported that, in 2009, nearly 
one-quarter of Medicare beneficiaries had greater than four 
comorbid conditions.27 The prevalence of polypharmacy, 
or use of multiple concurrent medications, increases with 
advanced age.30 Polypharmacy is also associated with a higher 
potential for ADRs, with worse outcomes in the elderly.31,32 
The relationship between polypharmacy and ADRs among 
older adults is likely due to age-related changes in physiol-
ogy, as well as pharmacodynamics and pharmacokinetics of 
medications.32,33 Close to two-thirds of our study population 
(68.8%) received a total of four prescriptions during their out-
patient visits. Furthermore, in our sample, patients using four 
or fewer medications were 12.4 times more likely to be pre-
scribed NSAIDs for persistent nonmalignant pain compared 
to patients with five or more medications. The prevention of 
ADRs by prescribing appropriate medications for multiple 
comorbidities while protecting patients from polypharmacy 
and following published AGS guidelines may be a possible 
explanation as to how patients with polypharmacy (at least 
five medications) were less likely to get NSAIDs for chronic 
pain management in our study. This cross-sectional survey is 
limited in reporting physicians’ knowledge or attitude toward 
prescribing and whether or not they followed AGS guidelines. 
A separate future survey on physicians’ knowledge and atti-
tudes on the relevant topic may help confirm assumptions 
based on our findings.
Opioids and adjuvant agents are recommended for mod-
erate to severe pain, as well as pain that causes functional 
impairment or diminishes quality of life. Our data showed 
that approximately 10% of the older adults receiving NSAIDs 
prescriptions also used an opioid drug, while 26% also used 
some type of adjuvant agent (such as a tricyclic antidepressant 
[TCA] or muscle relaxant). Previous estimates of opiate use 
among older adults living at home ranged between 2.8% and 
6.6%, and about 30% among the nursing home residents 
suffering from persistent nonmalignant pain.17,34 In compari-
son, a study of community-dwelling older adults in Finland 
reported that 18.5% received opiate prescriptions for pain 
relief.13 Like NSAIDs, opioid drugs possess the potential for 
ADRs in older adults, including delirium, gastrointestinal 
symptoms, respiratory depression, and increased risk of 
injuries due to falls, thereby presenting a barrier to the long-
term use of opioids.35–37 In addition to guidelines for opioids 
(as appropriate based on clinicians’ assessment) for uncon-
trolled persistent nonmalignant pain, the AGS also provides 
recommendation for adjuvant therapies.4 The guidelines for 
adjuvant therapies provide information on side effects includ-
ing those of high significance due to serious consequences, 
eg, fall and related injuries, confusion or deliriums. TCAs 
are adjuvants with “significant” side effects (as described in 
the AGS guidelines) and therefore, are recommended to be 
avoided in patients with syncope or delirium and to be used 
only when other suitable medications are contraindicated 
for those patients.38 Muscle relaxants are another group of 
medications with severe side effects, eg, fall, a “never” event 
for older hospitalized patients. Although not very high in per-
centages, both TCAs and muscle relaxants were prescribed as 
adjuvants in our study sample. Our study is limited in scope 





to describe whether specific comorbidities would make it 
inappropriate to use adjuvants (eg, TCAs and muscle relax-
ants) in our study population. Yet, the use of adjuvants with 
significant side effects that are also listed as inappropriate 
for use in the elderly by Beer’s criteria4,38 indicates the need 
to evaluate and educate prescribers on AGS guidelines for 
persistent nonmalignant pain management. Future research 
on prescription pattern by physicians may help explore the 
need for educational intervention.
Older adults are more likely to be hospitalized due to 
ADRs than younger patients,39,40 and about 23% of hospital 
admissions for older adults in the US occur due to ADRs 
related to NSAIDs.41 Further, NSAIDs are thought to be 
responsible for ten to 20 of every 1,000 hospitalizations.42 
A recent survey of 1,572 Veterans Affairs Medical Center 
patients (mean age =61 years) reported that 32% used 
NSAIDs inappropriately, either because they used more than 
one NSAIDs, exceeded the maximum suggested daily dos-
age, or both. Reported ADRs for NSAIDs among the elderly 
include gastrointestinal bleeding, cardiovascular events, and 
renal toxicity.43–46 The risks are greater among older adults 
with reduced creatinine clearance, cardiovascular disease, or 
gastropathy. Moreover, a concomitant use of NSAIDs with 
low-dose aspirin use for cardioprotective purposes increases 
the possibility for gastrointestinal effects in the vulnerable 
elderly population.4 Therefore, it is often recommended 
that older persons taking a nonselective NSAID or COX-2 
selective inhibitor with aspirin also obtain a prescription 
for a proton pump inhibitor, H
2
 receptor antagonist, or a 
similar appropriate medication to ensure gastroprotection.4 
The inappropriate NSAIDs users reported significantly more 
gastrointestinal symptoms and more pain in the previous 
week compared to the appropriate NSAIDs users.47 While 
pain severity and length of treatment are not reported in 
NAMCS to fully determine the appropriate use of NSAIDs in 
older adults, it is imperative to further explore if appropriate 
guidelines are applied for pain management in these patients 
who are at higher risk of ADRs due to NSAIDs use.
limitations
The NAMCS database is limited to up to six to eight drugs 
per patient visit. The cross-sectional nature of the NAMCS 
data limits us from knowing if prescriptions written were 
actually dispensed or filled by the patients, and for how 
long they were using these medications. Pain was defined 
as chronic or persistent, but level of severity is not reported 
in the NAMCS dataset.
Conclusion
A large percentage of older adults were prescribed NSAIDs 
for the management of persistent nonmalignant pain in 
US outpatient settings. While pain severity and length of 
 treatment are not reported in NAMCS to fully determine 
appropriate use of NSAIDs in older adults, we report a con-
sistent trend of NSAIDs use between 2000 and 2007, and that 
a large percentage of prescriptions were written by PCPs. Our 
data also report some use of adjuvant medications that are 
inappropriate for geriatric patients, which is also incongruent 
with AGS guidelines for persistent pain management. Future 
follow-up with actual prescription refill data is imperative to 
explore the extent of appropriate medication use according to 
AGS guidelines for persistent pain management in patients at 
high risk of ADRs. Lower percentages of NSAIDs prescrip-
tions written by PCPs, particularly by geriatric specialists, is 
an encouraging indication that continuation of care by these 
physicians is important in appropriate persistent nonmalig-
nant pain management in the vulnerable community-dwelling 
elderly population in the US.
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